Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.42 USD | -1.09% | +10.58% | -29.45% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.45% | 146M | |
+33.80% | 50.85B | |
+0.33% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.94% | 26.11B | |
-22.01% | 19.13B | |
+8.80% | 13.05B | |
+27.10% | 12.16B | |
+24.47% | 12.08B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Transcript : Syros Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 2022